• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA miR-1、miR-133a、miR-133b、miR-208a和miR-208b在慢性恰加斯病性心肌病中表达失调。

MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy.

作者信息

Ferreira Ludmila Rodrigues Pinto, Frade Amanda Farage, Santos Ronaldo Honorato Barros, Teixeira Priscila Camillo, Baron Monique Andrade, Navarro Isabela Cunha, Benvenuti Luiz Alberto, Fiorelli Alfredo Inácio, Bocchi Edimar Alcides, Stolf Noedir Antonio, Chevillard Christophe, Kalil Jorge, Cunha-Neto Edecio

机构信息

Laboratory of Immunology, Heart Institute (InCor), University of São Paulo, School of Medicine, São Paulo, Brazil; Division of Clinical Immunology and Allergy, University of São Paulo, School of Medicine, São Paulo, Brazil; Institute for Investigation in Immunology (iii), INCT, 05403-001, São Paulo, Brazil.

Division of Surgery, Heart Institute (InCor), University of São Paulo, School of Medicine, São Paulo, Brazil.

出版信息

Int J Cardiol. 2014 Aug 20;175(3):409-17. doi: 10.1016/j.ijcard.2014.05.019. Epub 2014 May 17.

DOI:10.1016/j.ijcard.2014.05.019
PMID:24910366
Abstract

BACKGROUND/METHODS: Chagas disease is caused by an intracellular parasite, Trypanosoma cruzi, and it is a leading cause of heart failure in Latin America. The main clinical consequence of the infection is the development of a Chronic Chagas disease Cardiomyopathy (CCC), which is characterized by myocarditis, hypertrophy and fibrosis and affects about 30% of infected patients. CCC has a worse prognosis than other cardiomyopathies, like idiopathic dilated cardiomyopathy (DCM). It is well established that myocardial gene expression patterns are altered in CCC, but the molecular mechanisms underlying these differences are not clear. MicroRNAs are recently discovered regulators of gene expression, and are recognized as important factors in heart development and cardiovascular disorders (CD). We analyzed the expression of nine different miRNAs in myocardial tissue samples of CCC patients in comparison to DCM patients and samples from heart transplant donors. Using the results of a cDNA microarray database on CCC and DCM myocardium, signaling networks were built and nodal molecules were identified.

RESULTS

We observed that five miRNAs were significantly altered in CCC and three in DCM; importantly, three miRNAs were significantly reduced in CCC as compared to DCM. We observed that multiple gene targets of the differentially expressed miRNAs showed a concordant inverse expression in CCC. Significantly, most gene targets and involved networks belong to crucial disease-related signaling pathways.

CONCLUSION

These results suggest that miRNAs may play a major role in the regulation of gene expression in CCC pathogenesis, with potential implication as diagnostic and prognostic tools.

摘要

背景/方法:恰加斯病由细胞内寄生虫克氏锥虫引起,是拉丁美洲心力衰竭的主要病因。感染的主要临床后果是慢性恰加斯病性心肌病(CCC)的发展,其特征为心肌炎、心肌肥厚和纤维化,约30%的感染患者会受影响。与其他心肌病如特发性扩张型心肌病(DCM)相比,CCC的预后更差。已明确在CCC中心肌基因表达模式发生改变,但这些差异背后的分子机制尚不清楚。微小RNA是最近发现的基因表达调节因子,被认为是心脏发育和心血管疾病(CD)中的重要因素。我们分析了CCC患者心肌组织样本中9种不同微小RNA的表达,并与DCM患者及心脏移植供体的样本进行比较。利用CCC和DCM心肌的cDNA微阵列数据库结果,构建了信号网络并鉴定了节点分子。

结果

我们观察到CCC中有5种微小RNA显著改变,DCM中有3种;重要的是,与DCM相比,CCC中有3种微小RNA显著降低。我们观察到差异表达微小RNA的多个基因靶点在CCC中呈现一致的反向表达。值得注意的是,大多数基因靶点和相关网络属于关键的疾病相关信号通路。

结论

这些结果表明微小RNA可能在CCC发病机制中的基因表达调控中起主要作用,具有作为诊断和预后工具的潜在意义。

相似文献

1
MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy.微小RNA miR-1、miR-133a、miR-133b、miR-208a和miR-208b在慢性恰加斯病性心肌病中表达失调。
Int J Cardiol. 2014 Aug 20;175(3):409-17. doi: 10.1016/j.ijcard.2014.05.019. Epub 2014 May 17.
2
Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients.克氏锥虫病心肌病患者心脏中多个线粒体能量代谢途径的损伤。
Front Immunol. 2021 Nov 12;12:755782. doi: 10.3389/fimmu.2021.755782. eCollection 2021.
3
Whole-Genome Cardiac DNA Methylation Fingerprint and Gene Expression Analysis Provide New Insights in the Pathogenesis of Chronic Chagas Disease Cardiomyopathy.全基因组心脏 DNA 甲基化指纹图谱和基因表达分析为慢性恰加斯病心肌病的发病机制提供新的见解。
Clin Infect Dis. 2017 Oct 1;65(7):1103-1111. doi: 10.1093/cid/cix506.
4
Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy.循环 miRNA 作为与恰加斯病心肌病心脏重构和纤维化相关的潜在生物标志物。
Int J Mol Sci. 2019 Aug 20;20(16):4064. doi: 10.3390/ijms20164064.
5
miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy.miRNAs 可能在恰加斯病心肌病的关键病理生物学过程中的基因表达调控中发挥主要作用。
PLoS Negl Trop Dis. 2020 Dec 22;14(12):e0008889. doi: 10.1371/journal.pntd.0008889. eCollection 2020 Dec.
6
[Vector electrocardiographic findings in chronic Chagas cardiomyopathy].[慢性恰加斯心肌病的向量心电图表现]
Arch Inst Cardiol Mex. 1998 Jan-Feb;68(1):51-7.
7
Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.抑制miR-208b可改善基于肌联蛋白的扩张型心肌病的心脏功能。
Int J Cardiol. 2017 Mar 1;230:634-641. doi: 10.1016/j.ijcard.2016.12.171. Epub 2016 Dec 28.
8
Myocardial gene and protein expression profiles after autoimmune injury in Chagas' disease cardiomyopathy.自身免疫性损伤后克山病心肌病的心肌基因和蛋白质表达谱。
Autoimmun Rev. 2011 Jan;10(3):163-5. doi: 10.1016/j.autrev.2010.09.019. Epub 2010 Sep 29.
9
Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease.治疗性 miR-21 沉默可减少慢性恰加斯病的心肌纤维化并调节炎症反应。
Int J Mol Sci. 2021 Mar 24;22(7):3307. doi: 10.3390/ijms22073307.
10
Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.慢性查加斯病性心肌病患者对克氏锥虫感染表现出增强的γ干扰素反应。
J Autoimmun. 2001 Aug;17(1):99-107. doi: 10.1006/jaut.2001.0523.

引用本文的文献

1
Investigation of the Expression Levels of miR-155, miR-133a, and miR-146b in the Serum of Acute and Chronic Forms of Cutaneous Leishmaniasis.急性和慢性皮肤利什曼病患者血清中miR-155、miR-133a和miR-146b表达水平的研究
Acta Parasitol. 2025 Aug 19;70(5):185. doi: 10.1007/s11686-025-01123-x.
2
Ninoa Strain Modifies the Expression of microRNAs in Cardiac Tissue and Plasma During Chagas Disease Infection.尼诺阿菌株改变恰加斯病感染期间心脏组织和血浆中微小RNA的表达。
Pathogens. 2024 Dec 20;13(12):1127. doi: 10.3390/pathogens13121127.
3
The characteristic expression of circulating in osteoporosis: a systematic review and meta-analysis.
骨质疏松症中循环标志物的特征性表达:一项系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2024 Dec 16;15:1481649. doi: 10.3389/fendo.2024.1481649. eCollection 2024.
4
The Role of MicroRNA in the Pathophysiology and Diagnosis of Viral Myocarditis.MicroRNA 在病毒性心肌炎的病理生理学和诊断中的作用。
Int J Mol Sci. 2024 Oct 11;25(20):10933. doi: 10.3390/ijms252010933.
5
Unraveling the role of miRNAs as biomarkers in Chagas cardiomyopathy: Insights into molecular pathophysiology.解析 miRNA 作为恰加斯心肌病生物标志物的作用:分子病理生理学的见解。
PLoS Negl Trop Dis. 2024 Feb 1;18(2):e0011865. doi: 10.1371/journal.pntd.0011865. eCollection 2024 Feb.
6
Discovery of circulating miRNAs as biomarkers of chronic Chagas heart disease via a small RNA-Seq approach.通过小 RNA-Seq 方法发现循环 miRNA 作为慢性恰加斯心脏病的生物标志物。
Sci Rep. 2024 Jan 12;14(1):1187. doi: 10.1038/s41598-024-51487-9.
7
Circulating microRNAs as biomarkers of Chagas cardiomyopathy.循环微RNA作为恰加斯心肌病的生物标志物
Front Cardiovasc Med. 2023 Dec 19;10:1250029. doi: 10.3389/fcvm.2023.1250029. eCollection 2023.
8
MiRNA-146a-A Key Player in Immunity and Diseases.miRNA-146a:免疫与疾病中的关键分子
Int J Mol Sci. 2023 Aug 14;24(16):12767. doi: 10.3390/ijms241612767.
9
Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches.推进心肌炎的精准医学:基于心内膜心肌活检的诊断和治疗方法的现状与未来展望
J Clin Med. 2023 Jul 31;12(15):5050. doi: 10.3390/jcm12155050.
10
Comparative microRNA profiling of infected human cells.感染人类细胞的 microRNA 表达谱比较分析。
Front Cell Infect Microbiol. 2023 Jun 21;13:1187375. doi: 10.3389/fcimb.2023.1187375. eCollection 2023.